跳至主導覽
跳至搜尋
跳過主要內容
國立陽明交通大學研發優勢分析平台 首頁
English
中文
首頁
人員
單位
研究成果
計畫
獎項
活動
貴重儀器
影響
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
宋 思賢
教授
醫學系內科學科
電子郵件
shsang
vghtpe.gov
tw
網站
https://cv.nycu.edu.tw/?action=member&id=46&lang=tw
h-index
h10-index
h5-index
4456
引文
34
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2627
引文
26
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
723
引文
10
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2007
2024
每年研究成果
概覽
指紋
網路
研究成果
(204)
類似的個人檔案
(6)
指紋
查看啟用 Shih-Hsien Sung 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Keyphrases
Acute Heart Failure
86%
Taiwan
76%
Cardiovascular Mortality
69%
Percutaneous Coronary Intervention
69%
Taiwan Society of Cardiology
65%
All-cause Mortality
65%
Clinical Outcomes
62%
Heart Failure with Preserved Ejection Fraction (HFpEF)
55%
Confidence Interval
53%
Systolic Blood Pressure
52%
Hazard Ratio
51%
Blood Pressure
48%
Heart Failure
47%
Central Blood Pressure
40%
Hypertension
39%
Atrial Fibrillation
39%
Patients with Heart Failure
37%
Meta-analysis
37%
Major Adverse Cardiovascular Events
36%
Randomized Controlled Trial
36%
Myocardial Infarction
36%
Wave Reflection
35%
Central Systolic Blood Pressure
31%
Arterial Stiffness
31%
Severe Mitral Regurgitation
30%
Pulmonary Arterial Hypertension
29%
Risk Stratification
29%
Body Mass Index
28%
Diastolic Blood Pressure
27%
Acute Coronary Syndrome
27%
Cardiovascular Events
27%
Carotid-femoral Pulse Wave Velocity (cfPWV)
26%
Left Ventricular Ejection Fraction
25%
Coronary Intervention
25%
Systematic Meta-analysis
25%
Pulsatile Hemodynamics
24%
Coronary Artery Disease
24%
Pressure Wave
24%
Oscillometric Blood Pressure Measurement
24%
Fabry Disease
23%
Hypertension Management
23%
Prognostic Value
23%
Heart Failure Patients
22%
High Risk
21%
Brachial
21%
Central Aortic Pressure
21%
Left Ventricular Hypertrophy
21%
Cardiovascular Outcomes
21%
MitraClip
20%
N-terminal Pro-brain Natriuretic Peptide (NT-proBNP)
20%
Medicine and Dentistry
Cardiovascular System
100%
Congestive Heart Failure
95%
Blood Pressure
88%
Acute Decompensated Heart Failure
72%
Systolic Blood Pressure
67%
Cardiology
65%
Percutaneous Coronary Intervention
59%
Coronary Artery Disease
55%
All Cause Mortality
45%
Hazard Ratio
43%
Pulse Wave Velocity
43%
Hemodynamic
40%
Myocardial Infarction
37%
Pulse Rate
36%
Cardiovascular Mortality
36%
Apoplexy
35%
Mitral Insufficiency
35%
Pulmonary Hypertension
34%
Cardiovascular Disease
32%
Heart Failure with Reduced Ejection Fraction
29%
Cardiovascular Risk
29%
Randomized Controlled Trial
28%
Fabry Disease
28%
Heart Left Ventricle Ejection Fraction
25%
Acute Coronary Syndrome
22%
Arterial Stiffness
21%
Pulse Pressure
21%
Atrial Fibrillation
20%
Kidney Function
20%
Mitral Valve Repair
19%
Left Ventricular Hypertrophy
19%
Drug-Eluting Stent
19%
Body Mass Index
19%
Adverse Event
18%
Ejection Fraction
18%
Coronary Artery Bypass Graft
18%
Population Research
18%
Risk Stratification
17%
Blood Pressure Measurement
17%
Systematic Review
16%
Exercise
16%
Meta-Analysis
16%
Comorbidity
16%
Systolic Heart Failure
16%
Aortic Pressure
15%
Blood Pressure Variability
15%
Coronary Artery Bypass Surgery
15%
Left Coronary Artery
15%
Heart Muscle Biopsy
14%
Amino Terminal Sequence
14%
